Navigation Links
Genetics society and cell biologists partner for life sciences education journal
Date:9/5/2013

BETHESDA, MD, SEPTEMBER 4, 2013--Behind the acronyms GSA + ASCB = LSE stands a new editorial partnership between the Genetics Society of America (GSA) and the American Society for Cell Biology (ASCB) to support the online journal, CBELife Sciences Education (LSE). Today, the two societies announced the joint editorial partnership in the latest issue of LSE. The journal was started by ASCB in 2002 as Cell Biology Education but changed its name to CBELife Sciences Education in 2006 to reflect the breadth of its coverage, which spans topics in education across all life science disciplines. GSA will become a full editorial partner, promoting the journal, soliciting manuscripts, and helping to defray, in part, the costs of operation while ASCB will remain the only publisher. The journal will have a joint editorial board drawn from scientists in both societies as well as from other disciplines. The current editor, Erin Dolan, PhD from the University of Georgia, will continue as LSE Editor-In-Chief.

In a joint editorial published yesterday in the new Fall 2013 issue of LSE, the executive directors of the two societies, Stefano Bertuzzi, PhD, for ASCB, and Adam P. Fagen, PhD, for GSA, say that the journal, which has become known for its data-driven analysis and evidence-based approach to improved teaching of the life sciences at all levels, has never been more important than in today's crisis atmosphere of plummeting budgets, workforce uncertainty, and lagging public knowledge about science. "From K-12 to secondary and higher education and lifelong learning, science education is in desperate need of data-driven reform, reinvestment, and reinvigoration," they write.

Fagen and Bertuzzi continue, "ASCB and GSA believe that there is neither time nor room for flag planting and parochialism. Rather than remaining only in our own sil
'/>"/>

Contact: John Fleischman
jfleischman@ascb.org
513-706-0212
American Society for Cell Biology
Source:Eurekalert

Page: 1 2

Related biology news :

1. Researchers untangle genetics of drug resistant TB
2. Unscrambling the genetics of the chickens blue egg
3. European Society of Human Genetics urges caution over use of new genetic sequencing techniques
4. Genetics Society of Americas GENETICS journal highlights for May 2013
5. Genetics defines a distinct liver disease
6. Ludwig presents advancements in immunotherapy and epigenetics at the American Association for Cancer Research Annual Meeting
7. Ludwig advancements in immunotherapy and epigenetics top scientific program at AACR
8. Genetics Society of Americas Genetics journal highlights for April 2013
9. Epigenetics studies take root in plants
10. Education resource focuses on teaching population genetics using current research
11. Spiral Genetics Closes $3 Million in Funding Led by DFJ and Announces Partnership with Omicia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... , May 28, 2015 Research and ... of the "Facial Recognition Market by Solution, ... Global Forecast to 2020" report to their ... seen facial recognition technology become more efficient and ... gain traction and investment from the commercial sector. ...
(Date:5/28/2015)... GLEN ALLEN, Va. , May 28, 2015 ... announced the release of a new report titled ... self-healing materials (reversible polymers, inorganic capsule and vascular ... self-healing coatings) will grow to around $2.7 billion ... latest deliverable from n-tech,s extensive coverage of smart ...
(Date:5/27/2015)... 2015   Codonics (codonics.com), a ... image documentation solutions and Omnicell  (omnicell.com), ... solutions, is pleased to announce their state ... Label System® (SLS), an award-winning FDA class ... Omnicell Anesthesia Workstation, helps prevent medication errors, ...
Breaking Biology News(10 mins):Global advanced Facial Recognition Market Expected to Grow From $2.77 Billion in 2015 to $6.19 Billion in 2020, at an Estimated CAGR of 17.4% 2The Market for Self-Healing Materials to Reach $2.7 Billion by 2020 Says New n-tech Research Study 2The Market for Self-Healing Materials to Reach $2.7 Billion by 2020 Says New n-tech Research Study 3Codonics and Omnicell Expand Partnership 2Codonics and Omnicell Expand Partnership 3Codonics and Omnicell Expand Partnership 4
... by the problem of "super-bugs" - bacteria that have ... that a high rate of antibiotic prescribing in hospitals ... for some antibiotics, an even more important factor contributing ... the open access international medical journal PLoS Medicine, is ...
... have made an important discovery that will advance our ... of breast cancer cells. The research, in collaboration with ... (IRCM) identifies 153 genes that respond to estrogen and ... the growth of breast cancer cells. The study, published ...
... such as corn, soybeans and sunflowers into fuel uses ... generates, according to a new Cornell University and University ... benefit to using plant biomass for liquid fuel," says ... "These strategies are not sustainable." , Pimentel and Tad ...
Cached Biology News:Agricultural antibiotic use contributes to 'super-bugs' in humans 2Scientists discover genetic pathway responsible for breast cancer cell growth 2Using the genomic shortcut to predict bacterial behavior 2
(Date:5/30/2015)... CTI BioPharma Corp. (CTI BioPharma) (NASDAQ and MTA: CTIC) ... today announced data from PERSIST-1 – a randomized Phase ... myelofibrosis – in a late-breaking oral session at the ... Clinical Oncology (ASCO), May 29-June 2, 2015 in ... oral multikinase inhibitor with specificity for JAK2 and FLT3. ...
(Date:5/30/2015)... CHICAGO and RARITAN, N.J. ... the international, multi-center, open-label, two-part, single-arm Phase 2 ... – an investigational, human anti-CD38 monoclonal antibody – ... percent (95% CI, 20.8-38.9), as assessed by an ... multiple myeloma. The ORR was consistent among the ...
(Date:5/30/2015)... 2015  Caris Life Sciences® today announced the ... researchers identified biomarker changes, including key driver mutations, ... changes in response to therapy as the disease ... subset of a larger study analyzing 1,245 glioma ... These data utilizing Caris Molecular Intelligence®, the company,s ...
(Date:5/29/2015)... HILL, N.C. , May 29, 2015 /PRNewswire/ ... medical affairs function into roles involving clinical development, ... As its responsibilities have grown, Medical Affairs has ... function as a global group. And while its ... find it challenging to identify strong performance metrics ...
Breaking Biology Technology:Phase 3 Pacritinib Study Shows Significant Clinically Meaningful Results In Patients With Myelofibrosis In Late-Breaking Session At ASCO 2015 2Phase 3 Pacritinib Study Shows Significant Clinically Meaningful Results In Patients With Myelofibrosis In Late-Breaking Session At ASCO 2015 3Phase 3 Pacritinib Study Shows Significant Clinically Meaningful Results In Patients With Myelofibrosis In Late-Breaking Session At ASCO 2015 4Phase 3 Pacritinib Study Shows Significant Clinically Meaningful Results In Patients With Myelofibrosis In Late-Breaking Session At ASCO 2015 5Phase 3 Pacritinib Study Shows Significant Clinically Meaningful Results In Patients With Myelofibrosis In Late-Breaking Session At ASCO 2015 6Phase 3 Pacritinib Study Shows Significant Clinically Meaningful Results In Patients With Myelofibrosis In Late-Breaking Session At ASCO 2015 7Phase 3 Pacritinib Study Shows Significant Clinically Meaningful Results In Patients With Myelofibrosis In Late-Breaking Session At ASCO 2015 8Phase 3 Pacritinib Study Shows Significant Clinically Meaningful Results In Patients With Myelofibrosis In Late-Breaking Session At ASCO 2015 9Phase 3 Pacritinib Study Shows Significant Clinically Meaningful Results In Patients With Myelofibrosis In Late-Breaking Session At ASCO 2015 10Data Show Daratumumab Achieved a Pronounced Overall Response Rate as a Single-Agent with Tolerable Safety Profile in Heavily Pre-Treated Multiple Myeloma Patients 2Data Show Daratumumab Achieved a Pronounced Overall Response Rate as a Single-Agent with Tolerable Safety Profile in Heavily Pre-Treated Multiple Myeloma Patients 3Data Show Daratumumab Achieved a Pronounced Overall Response Rate as a Single-Agent with Tolerable Safety Profile in Heavily Pre-Treated Multiple Myeloma Patients 4Data Show Daratumumab Achieved a Pronounced Overall Response Rate as a Single-Agent with Tolerable Safety Profile in Heavily Pre-Treated Multiple Myeloma Patients 5Data Show Daratumumab Achieved a Pronounced Overall Response Rate as a Single-Agent with Tolerable Safety Profile in Heavily Pre-Treated Multiple Myeloma Patients 6Data Show Daratumumab Achieved a Pronounced Overall Response Rate as a Single-Agent with Tolerable Safety Profile in Heavily Pre-Treated Multiple Myeloma Patients 7Caris Life Sciences Paired Tumor Data Identifies Key Driver Mutations and Confirms Tumor Heterogeneity in High-Grade Glioma Samples 2Caris Life Sciences Paired Tumor Data Identifies Key Driver Mutations and Confirms Tumor Heterogeneity in High-Grade Glioma Samples 3Caris Life Sciences Paired Tumor Data Identifies Key Driver Mutations and Confirms Tumor Heterogeneity in High-Grade Glioma Samples 4Creating an Effective Pharmaceutical Medical Affairs Group with Global Capabilities 2
... N.C. A genetic tool used by medical researchers may ... microbes and viruses from drinking water. , In a series ... of genetic material could successfully target a matching portion of ... make it stop working. If this new approach can be ...
... - YM BioSciences Inc.,(AMEX: YMI , TSX: ... and commercializes differentiated products for patients worldwide,today announced ... its,anti-cancer drug nimotuzumab, a humanized monoclonal antibody that ... the 2008 American,Society of Clinical Oncology (ASCO) Annual ...
... presentation at the 14th,International Conference on Prenatal Diagnosis and ... Diagnostic.,I.D.Rh(D) is the first in a series of noninvasive ... maternal blood sample., The I.D.Rh(D) test diagnoses the ... and can be performed as early as ten weeks ...
Cached Biology Technology:Possible new approach to purifying drinking water 2Possible new approach to purifying drinking water 3NIMOTUZUMAB CLINICAL DATA PRESENTED AT ASCO ANNUAL MEETING 2NIMOTUZUMAB CLINICAL DATA PRESENTED AT ASCO ANNUAL MEETING 3NIMOTUZUMAB CLINICAL DATA PRESENTED AT ASCO ANNUAL MEETING 4Presentation at the 14th International Conference on Prenatal Diagnosis and Therapy Highlights Biocept's I.D.Rh(D) Prenatal Diagnostic 2
... A perfect complement to high-speed analytical techniques, the AutoTrace SPE is a powerful, ... the cartridge conditioning, sample loading and elution steps for large volumes aqueous solution ... ... ...
... optically clear polystyrene with frosted labeling ... for cell counting. 100% integrity tested. ... new product number, created to easily ... no availability yet, please order under ...
Cell Culture Flask, nontreated polystyrene...
... The Corning CellBIND surface is produced ... a more hydrophilic surface giving more consistent, ... yields. CellBIND enhances cell attachment and growth ... serum-free medium. • CellBIND may provide a ...
Biology Products: